Medical polyurethane foam dressing and preparation method thereof
A technology of polyurethane foam and water-based polyurethane, applied in medical science, bandages, etc., can solve problems such as yellowing and degradation, high toxicity, and poor product appearance, and achieve the effects of simple preparation method, low catalyst toxicity, and good environmental performance
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0025] A medical polyurethane foam dressing provided by the invention is composed of the following components in mass percentage: 55% to 70% of waterborne polyurethane prepolymer, 2% to 3.5% of catalyst, 6% to 10% of surfactant, cross-linking 0.5% to 5% of sodium alginate, 2% to 10% of sodium alginate, 2% to 10% of sodium carboxymethyl cellulose, 0.3% to 2.5% of anti-yellowing agent, and the balance of purified water; the water-based polyurethane prepolymer It is at least one of polyester type and polyether type, and the catalyst is triethylenediamine, bis(dimethylaminoethyl)ether, 4,4'-(1,2-ethylidene)bis At least one of morpholine, 2,2-dimorpholino diethyl ether, triethanolamine, sodium bicarbonate, the surfactant is L-64, L-62, P188, PEG2000, PEG4000 At least one, the cross-linking agent is a compound with two or more hydroxyl groups, such as at least one of glycerol, sorbitol, trimethylolpropane, and the anti-yellowing agent is β-( 3,5-di-tert-butyl-4-hydroxyphenyl) octad...
Embodiment 2
[0031] A medical polyurethane foam dressing provided by the invention is composed of the following components in mass percentage: 70% of water-based polyurethane prepolymer, 3% of catalyst, 9% of surfactant, 3% of crosslinking agent, and 8% of sodium alginate , sodium carboxymethylcellulose 2%, anti-yellowing agent 0.8%, the balance of purified water; the catalyst is 2,2-dimorpholino diethyl ether: 4,4'-(1,2-ethyl Subunit) bismorpholine=9:1, the surfactant is P188, the crosslinking agent is glycerol, and the water-based polyurethane is polyether type.
[0032] The preparation method of described medical polyurethane foam dressing, it may further comprise the steps:
[0033] (1) Accurately weigh the catalyst, surfactant, crosslinking agent, sodium carboxymethyl cellulose and purified water according to the formula, stir at room temperature at a speed of 350r / min for 1h, and prepare the mixed material A. Put material A into an oven, and control the material temperature to 25°C....
Embodiment 3
[0037] A medical polyurethane foam dressing provided by the invention is composed of the following components by mass percentage: 60% water-based polyurethane prepolymer, 2.5% catalyst, 6% surfactant, 3% crosslinking agent, and 5% sodium alginate , sodium carboxymethyl cellulose 5%, anti-yellowing agent 0.5%, purified water surplus; the catalyst is triethanolamine, the surfactant is PEG2000, the cross-linking agent is sorbitol, the The water-based polyurethane is polyether type.
[0038] The preparation method of this embodiment is the same as that of embodiment 2.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com